The Effect of the Sodium—Glucose Cotransporter Inhibitor on Cognition and Metabolic Parameters in a Rat Model of Sporadic Alzheimer’s Disease

Type 2 diabetes mellitus increases the risk of sporadic Alzheimer’s disease (sAD), and antidiabetic drugs, including the sodium–glucose cotransporter inhibitors (SGLTI), are being studied as possible sAD therapy. We have explored whether the SGLTI phloridzin may influence metabolic and cognitive par...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmanović Barilar, Jelena, Babić Perhoč, Ana, Knezović, Ana, Homolak, Jan, Virag, Davor, Šalković-Petrišić, Melita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135566/
https://www.ncbi.nlm.nih.gov/pubmed/37189641
http://dx.doi.org/10.3390/biomedicines11041025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135566/
https://www.ncbi.nlm.nih.gov/pubmed/37189641
http://dx.doi.org/10.3390/biomedicines11041025

Ejemplares similares